New consumer and employee personas have emerged during the pandemic and healthcare organizations must pay attention to these new pivotal groups — such as young workers who only know work-from-home and people who make investment decisions based on social media — in order to stay relevant in a post-pandemic world.
September 28, 2022 at Pegasus Park in Dallas is your opportunity to network with over 30 investors (a 6:1 ratio), meet select Employee Benefits Startups, and participate in expert panel discussions around mental health, pharmacy benefits, the cost of healthcare, reaching consumers and the future of digital health.
By Katie Adams Wednesday, September 21, 2022 5:27 PM
Providence is investing $712 million into new facilities in Orange County, California. The health system is adding a new medical center in both San Clemente and Rancho Mission Viejo , as well as a new patient tower for Providence Mission Hospital.
By Marissa Plescia Wednesday, September 21, 2022 5:17 PM
Behavioral health, primary care and outpatient visits accounted for more than 97% of telehealth claims received by Blue Cross NC over the last two years, according to newly released data from the payer. In response, Blue Cross NC will begin covering telehealth for these services. But it will not cover telehealth for areas that were found less effective when provided virtually, such as laboratory testing and radiology.
By Dan Leibu Wednesday, September 21, 2022 3:06 PM
These are the three changes health-tech needs to make to recreate Amazon, Uber or Venmo-like experiences in healthcare that will most accurately help to digitally replicate the humanized interactions that patients want:
By Marissa Plescia Wednesday, September 21, 2022 2:29 PM
AHA's report comes after the U.S. House of Representatives passed the Improving Seniors' Timely Access to Care Act, which would establish several requirements for the prior authorization process under MA plans. But AHA believes additional action is needed by the government.
By Frank Vinluan Wednesday, September 21, 2022 12:56 PM
A Fennec Pharmaceuticals drug that prevents hearing loss in children receiving cancer treatment is now approved. The regulatory decision comes more than two years later than expected, but the company now claims its drug, Pedmark, is the first and only FDA-approved therapy for reducing the risk of chemotherapy-induced hearing loss in pediatric cancer patients.
No comments